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Abstract
52-year-old patient presented with palpitation and well tolerated monomorphic ventricular 
tachycardia. He had normal echocardiogram and coronary angiogram 3 months prior to 
presentation. Surface EKG revealed regular wide-complex tachycardia with right bundle branch 
block morphology and right inferior axis. In conjunction with recent negative cardiac evaluation, 
this suggested idiopathic focal ventricular tachycardia from anterolateral basal left ventricle. 
CARTO   based   activation   mapping   confirmed   the   presence   of   VT   focus   in   that   area. 
Radiofrequency ablation at the site of perfect pacemap resulted in a partial suppression of the 
focus. Echocardiogram was subsequently performed because of progressive dyspnea. It revealed 
asymmetrical thickening of posterolateral left ventricle, with delayed enhancement on contrast 
magnetic resonance imaging. Fine needle aspiration of abdominal fat stained with Congo red 
confirmed the diagnosis of systemic AL amyloidosis due to IgG  λ-light chain deposition. 
Consequently, the patient underwent placement of implantable defibrillator and hematopoetic 
stem cell transplantation. He remains in excellent functional status 18 months after presentation.
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Case   Report                                                                                    
A 52-year-old male was evaluated in an emergency room because of palpitations lasting 18 
hours. A 12-lead ECG revealed a regular wide-complex tachycardia with right inferior axis and 
right bundle branch block morphology, cycle length 400 msec and QRS duration 160 msec 
(Figure1A). The tachycardia was well tolerated and was not affected by carotid sinus massage. 
Before institution of any other treatment, the tachycardia terminated spontaneously and was 
replaced by sinus rhythm with frequent ventricular ectopy and nonsustained runs of the same 
morphology, confirming the initial suspicion of ventricular tachycardia (VT).
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Figure1: A Standard electrocardiogram of the presenting arrhythmia. No definite atrial activity can be seen and the 
QRS morphology is suggestive of ventricular tachycardia with a focus in basal anterolateral LV. This was 
confirmed during radiofrequency ablation. B Asymmetrical thickening of LV wall is seen on echocardiogram in 
parasternal long axis view (diastolic frame). The basal posterolateral wall thickness is 15 mm, while the thickness of 
the intervetricular septum appears normal. C Transmural delayed enhancement of posterolateral wall of the LV 
(arrow) on magnetic resonance image. Blood pool appears unusually dark on this T1 image because of gadolinium 
contrast uptake by amyloid deposits.
The patient had no known cardiac disease or prior arrhythmia. In the preceding 3 months, he had 
undergone detailed cardiac evaluation for symptoms of fatigue, questionable exercise intolerance 
and transient ischemic attack. At that time, his transthoracic echocardiogram was reported as 
normal. He was able to exercise for 10 minutes on Bruce protocol. Nuclear perfusion images 
were indicative of anterior wall ischemia, but subsequent coronary angiogram showed normal 
coronary arteries. The patient was otherwise healthy except for ulcerative colitis, which required 
colectomy 24 years ago, and monoclonal gammopathy of unknown significance (IgG λ-light 
chain, 1.48 g/dL) diagnosed 14 years earlier.                                               
Idiopathic focal VT with focus in basal anterolateral left ventricle (LV) was suspected in the 
emergency room, given the negative result of his recent thorough cardiac evaluation. Therefore, 
radiofrequency ablation was scheduled on the same day. Quadripolar electrophysiology catheters 
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were placed in high right atrium, along the His bundle, and to right ventricular apex initially. A 
steerable decapolar catheter was placed into coronary sinus. A 4 mm Navistar catheter by Cordis 
Webster was used in conjunction with the CARTO 3D mapping system for mapping and 
ablation. Prior to delivery of radiofrequency energy, this patient had frequent spontaneous 
ventricular ectopy and nonsustained runs of VT of the same morphology as the clinical VT. No 
VT induction was needed. Baseline AH and HV intervals were normal. VA block was seen 
during   500   ms   pacing.                                                                                
The VT was mapped primarily with activation mapping technique. Initial mapping of right 
ventricular outflow tract revealed only late signals as expected. LV was accessed with the 
retrograde approach; LV mapping localized the focus of the tachycardia to anterobasal LV, close 
to mitral valve annulus. A limited CARTO map suggested a single focus. Local activity preceded 
onset of surface QRS by 33 ms at this site. Pacemap from this site revealed 12/12 match with 
clinical VT morphology. Delivery of RF energy at this resulted in marked decrease in ectopic 
activity, although single premature ventricular beats and occasional couplets were still observed. 
The residual ectopy could not be eliminated during the procedure. Only relatively low powers 
(10-20 W) could be delivered at this site. The patient was discharged 3 days later on oral 
metoprolol, which resulted in nearly complete resolution of ventricular ectopy.              
Five days after discharge, the patient was evaluated for nocturnal dyspnea and atypical chest 
discomfort. Physical exam revealed mild bilateral lower extremity edema, and bilateral small 
pleural effusions were noted on chest X-ray.  Asymmetric LV thickening, most pronounced in 
the posterolateral wall of the LV, was found on transthoracic echocardiogram (Figure 1B). 
Cardiac magnetic resonance with gadolinium contrast showed asymmetric LV thickening (15 
mm posterolateral wall thickness). There was diffuse subendocardial and focal transmural 
enhancement on delayed images, along with unusually dark blood pool, indicative of increased 
gadolinium contrast clearance (Figure 1C) - a finding characteristic of amyloid cardiomyopathy 
[1]. Fine-needle aspirate of abdominal fat was stained with Congo red (Figure 2) and the result 
confirmed   the   diagnosis   of   systemic   amyloidosis.   The   patient   was   started   on   low-dose 
furosemide and implanted with a dual-chamber defibrillator. There was no obvious clinical 
involvement of any other organ, except the bone marrow, and he underwent successful 
hematopoietic stem cell transplantation 6 months after presentation. The monoclonal protein is 
no longer detectable in the serum. His functional status is excellent (NYHA I) 18 months after 
presentation, with no defibrillator discharges.  His LV ejection fraction remains normal, although 
the asymmetric LV thickening is still detected with echocardiography. 
Discussion
Cardiac   involvement   is   common   in   patients   with   amyloidosis   due   to   deposition   of 
immunoglobulin light chains [2]. Even though the heart is affected pathologically in 90% of cases, 
only 3.9% of cases have isolated cardiac involvement [3]. The most common presentation of 
cardiac amyloidosis is heart failure. The prognosis is usually poor, with median survival of 9 
months   after   the   onset   of   heart   failure.                                                                  
Approximately 30% of patients with cardiac involvement die suddenly [3]. Although many sudden 
deaths are caused by pulseless electrical activity, cardiac arrest due to ventricular arrhythmias is 
responsible in some cases [4-6]. A wide spectrum of ventricular arrhythmias occurs in patients 
with amyloid cardiomyopathy [7]. Nonsustained VT  is common  and correlates with poor survival 
[8,9]. Sustained ventricular arrhythmias have been recorded during resuscitated cardiac arrest [4] 
and by implantable defibrillators [5]. Radiofrequency ablation of ventricular fibrillation associated 
with cardiac amyloid deposition has also been reported [10]. However, well tolerated sustained 
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monomorphic VT mimicking idiopathic VT during EP study is very unusual and has not been 
associated with cardiac amyloid to the best of our knowledge.  Although formal entrainment was 
not performed due to brief duration of VT runs during the procedure, VT in this patient behaved as 
a triggered rather than reentrant arrhythmia: this VT started and terminated spontaneously, without 
need for VT pacing induction, and focal activation sequence was suggested by activation mapping. 
There were no low-voltage areas suggestive of scar in the anterobasal LV region. Partial success 
of radiofrequency ablation was obtained at the site of perfect pacemap. All of these features would 
be consistent a focal, presumably idiopathic VT; the presence of cardiac amyloid provided an 
alternative and unusual explanation. The tachycardia was likely caused by a focus of triggered 
activity in the border zone of transmural amyloid infiltration.
Figure 2: Abdominal fat pad fine needle aspiration smears stained positive with Congo red and exhibited apple-
green birefringence (inset) under polarized light.
 
Defibrillator implantation in amyloid cardiomyopathy is controversial because of limited survival 
in the affected patients [5,6]. However, the patient reported here had excellent functional status 
and no clinically apparent noncardiac involvement. He was felt to be a good candidate for 
aggressive therapy with hematopoietic stem cell transplant and potentially subsequent heart 
transplant [11,12]. Defibrillator implantation was thus warranted [13].                            
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